title: Depletion of intramuscularly injected ceftiofur from the milk of dairy cattle.
abstract: Ceftiofur sodium, a new broad-spectrum cephalosporin, has been approved in the US, Canada, and several other countries throughout the world to treat bovine respiratory disease in cattle and dairy cows. In Experiment 1, 6 lactating cows were intramuscularly treated with 2.29 mg of [14C]ceftiofur/kg of BW daily for 5 d. In Experiment 2, 30 additional cows at three locations were similarly treated with 2.2 mg of ceftiofur (unlabeled)/kg of BW. Milk was collected every 12 and 24 h after each dose and every 12 h up to 5 d after the last dose. The majority of milk samples, both during treatment (12 and 24 h after each dose) and after the last dose (up to 5 d following ceftiofur treatment), were negative by screening procedures based on microbial inhibition (Delvotest-P, Bacillus stearothermophilus disk assay, and cylinder plate assays). The receptor-binding Charm Test II assay, which has a limit of detection of .005 ppm of ceftiofur, gave positive tests for milk samples up to 48 h following treatment. When the Charm Test II assay is used with .008 IU/ml of penicillin as a positive control, 44% of the samples from individual cows were negative at 12 h posttreatment. Ninety percent of the samples from individual cows were negative at 24 h after the last treatment. The use of ceftiofur in dairy cattle in accordance with the label directions does not result in total residues in milk higher than the FDA-calculated safe concentration of 1-ppm ceftiofur equivalents. The milk from individual cows did not test positive by the commercial screening assays examined in this study, except for the Charm Test II. The Charm Test II was 90% negative using the Charm Sciences criteria at 24 h after the last treatment.
authors.affiliation: Upjohn Company, Kalamazoo, MI 49001.
authors.forename: P S
authors.initials: PS
authors.lastname: Jaglan
authors.forename: F S
authors.initials: FS
authors.lastname: Yein
authors.forename: R E
authors.initials: RE
authors.lastname: Hornish
authors.forename: B L
authors.initials: BL
authors.lastname: Cox
authors.forename: T S
authors.initials: TS
authors.lastname: Arnold
authors.forename: R D
authors.initials: RD
authors.lastname: Roof
authors.forename: T J
authors.initials: TJ
authors.lastname: Gilbertson
mesh_terms: D000818:Animals; D002417:Cattle / Q000378:metabolism* / Q000502:physiology; D002511:Cephalosporins / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D004350:Drug Residues / Q000032:analysis*; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D007774:Lactation / Q000378:metabolism*; D008892:Milk / Q000032:analysis*
chemical_list: D002511:Cephalosporins; C053503:ceftiofur